Bacterial cytochrome P450-catalyzed regio- and stereoselective steroid hydroxylation enabled by directed evolution and rational design

Abstract

Steroids are the most widely marketed products by the pharmaceutical industry after antibiotics. Steroid hydroxylation is one of the most important functionalizations because their derivatives enable a higher biological activity compared to their less polar non-hydroxylated analogs. Bacterial cytochrome P450s constitute promising biocatalysts for steroid hydroxylation due to their high expression level in common workhorses like Escherichia coli. However, they often suffer from wrong or insufficient regio- and/or stereoselectivity, low activity, narrow substrate range as well as insufficient thermostability, which hampers their industrial application. Fortunately, these problems can be generally solved by protein engineering based on directed evolution and rational design. In this work, an overview of recent developments on the engineering of bacterial cytochrome P450s for steroid hydroxylation is presented.

Keywords

Biocatalysis / Cytochrome P450 / Steroid hydroxylation / Regioselectivity / Stereoselectivity / Directed evolution / Rational design

References

[1] Acevedo-Rocha CG, Gamble C, Lonsdale R, Li A, Nett N, Hoebenreich S, Deege A. P450-catalyzed regio- and diastereoselective steroid hydroxylation: efficient directed evolution enabled by mutability landscaping. ACS Catal, 2018, 8(4): 3395-3410.

[2] Agematu H, Matsumoto N, Fujii Y, Kabumoto H, Doi S, Machia K, Arisawa A. Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci Biotech Bioch, 2006, 70(1): 307-311.

[3] Behrendorff JBYH, Gillam EMJ. Prospects for applying synthetic biology to toxicology: future opportunities and current limitations for the re-purposing of cytochrome P450 systems. Chem Res Toxicol, 2016, 30(1): 453-468.

[4] Behrendorff JB, Huang W, Gillam EM. Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity. Biochem J, 2015, 467(1): 1-15.

[5] Berg A, Gustafsson J, Ingelman-Sundberg M. Characterization of a cytochrome P-450-dependent steroid hydroxylase system present in Bacillus megaterium. J Biol Chem, 1976, 251(9): 2831-2838.

[6] Berg A, Ingelman-Sundberg M, Gustafsson J. Isolation and characterization of cytochrome P-450meg. Acta Biologica et Medica Germanica, 1979, 38: 333-344.

[7] Bernhardt R. Molecular evolution of a steroid hydroxylating cytochrome P450 using a versatile steroid detection system for screening. Lipids, 2008, 43(12): 1133-1141.

[8] Bernhardt R, Urlacher VB. Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl microbiol biot, 2014, 98(14): 6185-6203.

[9] Bleif S, Hannemann F, Lisurek M, von Kries JP, Zapp J, Dietzen M, Bernhardt R. Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase. ChemBioChem, 2011, 12(4): 576-582.

[10] Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R. A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-β-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl Microbiol Biotechnol, 2012, 93(3): 1135-1146.

[11] Bracco P, Janssen DB, Schallmey A. Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450. Microb Cell Fact, 2013, 12(1): 95.

[12] Coelho PS, Brustad EM, Kannan A, Arnold FH. Olefin cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes. Science, 2013, 339(6117): 307-310.

[13] Dangi B, Kim KH, Kang SH, Oh TJ. Tracking down a novel steroid hydroxylating promiscuous cytochrome P450, CYP154C8 from Streptomyces sp. W2233-SM. ChemBioChem, 2018, 19(10): 1066-1077.

[14] de Vlieger JS, Kolkman AJ, Ampt KA, Commandeur JN, Vermeulen NP, Kool J, Honing M. Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR. J Chromatogr B, 2010, 878(7–8): 667-674.

[15] Donova MV. Steroid bioconversions. Methods Mol Biol, 2017, 1645: 1-13.

[16] Donova MV, Egorova OV. Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol, 2012, 94(6): 1423-1447.

[17] Ewen KM, Hannemann F, Khatri Y, Perlova O, Kappl R, Krug D, Bernhardt R. Genome Mining in Sorangium cellulosum So ce56: identification and characterization of the homologous election transfer proteins of a myxobacteria cytochrome P450. J Biol Chem, 2009, 284(42): 28590.

[18] Fernandes P, Cruz A, Angelova B, Pinheiro HM, Cabral JMS. Microbial conversion of steroid compounds: recent developments. Enzyme Microb Tech, 2003, 32(6): 688-705.

[19] Geronimo I, Denning CA, Rogers WE, Othman T, Huxford T, Heidary DK, Payne CM. Effect of mutation and substrate binding on the stability of cytochrome P450BM3 variants. Biochemistry-US, 2016, 55(25): 3594-3606.

[20] Girhard M, Klaus T, Khatri Y, Bernhardt R, Urlacher VB. Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis. Appl Microbiol Biot, 2010, 87(2): 595-607.

[21] Girvan HM, Munro AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Curr Opin Chem Biol, 2016, 31: 136-145.

[22] Glieder A, Farinas ET, Arnold FH. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat Biotechnol, 2002, 20(11): 1135.

[23] Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem, 1992, 267(1): 83-90.

[24] Guengerich FP. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol, 2001, 14(6): 611-650.

[25] Guengerich FP. Cytochrome P450 enzymes in the generation of commercial products. Nat Rev Drug Discov, 2002, 1(5): 359.

[26] Guengerich FP. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys, 2003, 409(1): 59-71.

[27] Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol, 2008, 21(1): 70-83.

[28] Guengerich FP, Waterman MR, Egli M. Recent structural Insights into cytochrome P450 function. Trends Pharmacol Sci, 2016, 37(8): 625-640.

[29] Hannemann F, Bernhardt R. Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. J Biotechnol, 2006, 124(1): 172-181.

[30] Hartwig JF. Evolution of C–H bond functionalization from methane to methodology. J Am Chem Soc, 2015, 138(1): 2-24.

[31] Huang WC, Westlake AC, Maréchal JD, Joyce MG, Moody PC, Roberts GC. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency. J Mol Biol, 2007, 373(3): 633-651.

[32] Janocha S, Carius Y, Hutter M, Lancaster CRD, Bernhardt R. Crystal structure of CYP106A2 in substrate-free and substrate-bound form. ChemBioChem, 2016, 17(9): 852-860.

[33] Jóźwik IK, Kiss FM, Gricman Ł, Abdulmughni A, Brill E, Zapp J, Thunnissen AMW. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium. FEBS J, 2016, 283: 4128-4148.

[34] Kellner DG, Maves SA, Sligar SG. Engineering cytochrome P450s for bioremediation. Curr Opin Biotechnol, 1997, 8(3): 274-278.

[35] Khatri Y, Ringle M, Lisurek M, von Kries JP, Zapp J, Bernhardt R. Substrate hunting for the myxobacterial CYP260A1 revealed novel 1α-hydroxylated products from C-19 steroids. ChemBioChem, 2016, 17(1): 90-101.

[36] Khatri Y, Carius Y, Ringle M, Lancaster CRD, Bernhardt R. Structural characterization of CYP260A1 from Sorangium cellulosum to investigate the 1α-hydroxylation of a mineralocorticoid. FEBS Lett, 2016, 590(24): 4638.

[37] Khatri Y, Jóźwik IK, Ringle M, Ionescu IA, Litzenburger M, Hutter MC, Bernhardt R. Structure-based engineering of steroidogenic CYP260A1 for stereo- and regioselective hydroxylation of progesterone. ACS Chem Biol, 2018, 13(4): 1021-1028.

[38] Kille S, Zilly FE, Acevedo JP, Reetz MT. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution. Nat Chem, 2011, 3(9): 738-743.

[39] Kiss FM, Lundemo MT, Zapp J, Woodley JM, Bernhardt R. Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst. Microb Cell Fact, 2015, 14(1): 28.

[40] Kiss FM, Schmitz D, Zapp J, Dier TK, Volmer DA, Bernhardt R. Comparison of CYP106A1 and CYP106A2 from Bacillus megaterium—identification of a novel 11-oxidase activity. Appl Microbiol Biot, 2015, 99: 8495-8514.

[41] Kumar S, Halpert JR. Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts. Biochem Bioph Res Co, 2005, 338(1): 456-464.

[42] Lewis JC, Coelho PS, Arnold FH. Enzymatic functionalization of carbon-hydrogen bonds. Chem Soc Rev, 2011, 40(4): 2003-2021.

[43] Li Z, van Beilen JB, Duetz WA, Schmid A, de Raadt A, Griengl H, Witholt B. Oxidative biotransformations using oxygenases. Curr Opin Chem Biol, 2002, 6(2): 136-144.

[44] Li A, Liu J, Pham SQ, Li Z. Engineered P450pyr monooxygenase for asymmetric epoxidation of alkenes with unique and high enantioselectivity. Chem Commun, 2013, 49(98): 11572.

[45] Li A, Wu S, Adams JP, Snajdrona R, Li Z. Asymmetric epoxidation of alkenes and benzylic hydroxylation with P450tol monooxygenase from Rhodococcus coprophilus TC-2. Chem Commun, 2015, 45(52): 8771-8774.

[46] Li RJ, Xu JH, Yin YC, Wirth N, Ren JM, Zen BB, Yu HL. Rapid probing of the reactivity of P450 monooxygenases from the CYP116B subfamily using a substrate-based method. New J Chem, 2016, 40: 8928-8934.

[47] Li A, Ilie A, Sun Z. Whole-cell-catalyzed multiple regio- and stereoselective functionalizations in cascade reactions enabled by directed evolution. Angew Chem Int Ed, 2016, 128(39): 12205-12208.

[48] Li A, Wang B, Ilie A, Dubey KD, Bange G, Korendovych IV, Reetz MT. A redox-mediated Kemp eliminase. Nat Commun, 2017, 8: 14876.

[49] Lisurek M, Kang M, Hartmann R, Bernhardt R. Identification of monohydroxy progesterones produced by CYP106A2 using comparative HPLC and electrospray ionisation collision-induced dissociation mass spectrometry. Biochem Bioph Res Co, 2004, 319: 677-682.

[50] Lisurek M, Simgen B, Antes I, Bernhardt R. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation. ChemBioChem, 2008, 9(9): 1439-1449.

[51] Litzenburger M, Bernhardt R. CYP260B1 acts as 9α-hydroxylase for 11-deoxycorticosterone. Steroids, 2017, 127: 40-45.

[52] Litzenburger M, Kern F, Khatri Y, Bernhardt R. Conversions of tricyclic antidepressants and antipsychotics with selected P450s from Sorangium cellulosum So ce56. Drug Metab Dispos, 2015, 43(3): 392-399.

[53] Liu X, Kong JQ. Steroids hydroxylation catalyzed by the monooxygenase mutant 139-3 from Bacillus megaterium BM3. Acta Pharm Sin B, 2017, 7(4): 120-126.

[54] Liu X, Wang ZB, Wang YN, Kong JQ. Probing steroidal substrate specificity of cytochrome P450 BM3 variants. Molecules, 2016, 21(6): 760.

[55] Lussenburg BM, Babel LC, Vermeulen NP, Commandeur JN. Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants. Anal Biochem, 2005, 341(1): 148-155.

[56] Makino T, Katsuyama Y, Otomatsu T, Misawa N, Ohnishi Y. Regio- and stereospecific hydroxylation of various steroids at the 16α position of the D ring by the Streptomyces griseus cytochrome P450 CYP154C3. Appl Environ Microb, 2014, 80(4): 1371.

[57] Mallinson SJB, Machovina MM, Silveira RL, Garcia BM, Gallup N, Johnson CW, Houk KN. A promiscuous cytochrome P450 aromatic O-demethylase for lignin bioconversion. Nat Commun, 2018, 9(1): 2487.

[58] Morant M, Bak S, Møller BL, Werck-Reichhart D. Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation. Curr Opin Biotechnol, 2003, 14(2): 151-162.

[59] Munro AW, Girvan HM, Mclean KJ. Variations on a (t)heme–novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat Prod Rep, 2007, 24(3): 585-609.

[60] Narhi LO, Fulco AJ. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem, 1986, 261(16): 7160-7169.

[61] Nelson DR. Cytochrome P450 diversity in the tree of life. BBA-Proteins Proteom, 2018, 1866(1): 141-154.

[62] Nguyen KT, Günnewich N, Hannemann F, Bernhardt R. Changing the regioselectivity of a P450 from C15 to C11 hydroxylation of progesterone. ChemBioChem, 2012, 13(8): 1161-1166.

[63] Nikolaus J, Nguyen KT, Virus C, Riehm JL, Hutter M, Bernhardt R. Engineering of CYP106A2 for steroid 9α- and 6β-hydroxylation. Steroids, 2017, 120: 41-48.

[64] Oliver CF, Modi Sandeep, Sutcliffe Michael J, Primrose WU, Lian LY, Roberts Gordon CK. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regioselectivity of hydroxylation. Biochemistry-US, 1997, 36(7): 1567-1572.

[65] O’Reilly E, Corbett M, Hussain S, Kelly PP, Richardson D, Flitsch SL, Turner NJ. Substrate promiscuity of cytochrome P450 RhF. Catal Sci Technol, 2013, 3(6): 1490-1492.

[66] Podust LM, Sherman DH. Diversity of P450 enzymes in the biosynthesis of natural products. Nat Prod Rep, 2012, 29(10): 1251.

[67] Prier CK, Zhang RK, Buller AR, Brinkann-Chen S, Arnold FH. Enantioselective, intermolecular benzylic C–H amination catalyzed by an engineered iron-heme enzyme. Nat Chem, 2017, 9(7): 629.

[68] Qu G, Li A, Sun Z, Acevedo-Rocha CG, Reetz MT. The crucial role of methodology development in directed evolution of selective enzymes. Angew Chem Int Edit, 2019

[69] Rauschenbach R, Isernhagen M, Noeske-Jungblut C, Boidol W, Siewert G. Cloning sequencing and expression of the gene for cytochrome P450meg, the steroid-15β-monooxygenase from Bacillus megaterium ATCC 13368. Mol Gen Genet, 1993, 241: 170-176.

[70] Rea V, Kolkman AJ, Vottero E, Stronks EJ, Ampt KAM, Honing M, Commandeur JNM. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic Resonance studies. Biochemistry-US, 2012, 51(3): 750-760.

[71] Reetz MT. Controlling the enantioselectivity of enzymes by directed evolution: practical and theoretical ramifications. Proc Natl Acad Sci USA, 2004, 101(16): 5716-5722.

[72] Reetz MT. Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions. Angew Chem Int Ed, 2011, 50(1): 138-174.

[73] Reetz MT, Carballeira JD. Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes. Nat Protoc, 2007, 2(4): 891-903.

[74] Reetz MT, Krebs GPL. Challenges in the directed evolution of stereoselective enzymes for use in organic chemistry. C R Chime, 2011, 14(9): 818.

[75] Ren X, Yorke JA, Taylor E, Zhang T, Zhou W, Wong LL. Drug oxidation by cytochrome P450BM3: metabolite synthesis and discovering new P450 reaction types. Chem-Eur J, 2015, 21(42): 15039-15047.

[76] Renault H, Bassard JE, Hamberger B, Reichhart DW. Cytochrome P450-mediated metabolic engineering: current progress and future challenges. Curr Opin Plant Biol, 2014, 19(19C): 27-34.

[77] Ringle M, Khatri Y, Zapp J, Hannemann F, Bernhardt R. Application of a new versatile electron transfer system for cytochrome; P450-based Escherichia coli whole-cell bioconversions. Appl Microbiol Biotechnol, 2013, 97(17): 7741-7754.

[78] Roiban GD, Reetz MT. Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation. Chem Commun, 2014, 46(16): 2208-2224.

[79] Romdhane IB, Frikha F, Maalej-Achouri I, Gargouri A, Belghith H. Gene cloning and molecular characterization of the Talaromyces thermophilus lipase catalyzed efficient hydrolysis and synthesis of esters. Gene, 2012, 494(1): 112-118.

[80] Saab-Rincon G, Alwaseem H, Guzmán-Luna V, Olvera L, Fasan R. Stabilization of the reductase domain in the catalytically self-sufficient cytochrome P450BM3 via consensus-guided mutagenesis. ChemBioChem, 2017, 19(6): 622-632.

[81] Salamanca-Pinzon SG, Khatri Y, Carius Y, Keller L, Müller R, Lancaster CRD, Bernhardt R. Structure–function analysis for the hydroxylation of Δ4 C21-steroids by the myxobacterial CYP260B1. FEBS Lett, 2016, 590(12): 1838-1851.

[82] Schifrin A, Litzenburger M, Ringle M, Ly TT, Bernhardt R. New sesquiterpene oxidations with CYP260A1 and CYP264B1 from Sorangium cellulosum So ce56. ChemBioChem, 2015, 16(18): 2624-2632.

[83] Schmitz D, Janocha S, Kiss FM, Bernhardt R. CYP106A2—a versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds. BBA-Proteins Proteom, 2018, 1866(1): 11-22.

[84] Schmitz D, Zapp J, Bernhardt R. Hydroxylation of the triterpenoid dipterocarpol with CYP106A2 from Bacillus megaterium. FEBS J, 2012, 279(9): 1663-1674.

[85] Szaleniec M, Wojtkiewicz AM, Bernhardt R, Borowski T, Donova M. Bacterial steroid hydroxylases: enzyme classes, their functions and comparison of their catalytic mechanisms. Appl Microbiol Biol, 2018, 102(19): 8153-8171.

[86] Tokuriki N, Jackson CJ, Afriat-Jurnou L, Wyganowski KT, Tang R, Tawfik DS. Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme. Nat Commun, 2012, 3: 1257.

[87] Urlacher VB, Girhard M. Cytochrome p450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol, 2012, 30(1): 26-36.

[88] Urlacher VB, Marco G. Cytochrome p450 monooxygenases in biotechnology and synthetic biology. Trends Biotechnol, 2019, 37(8): 882-897.

[89] van Vugt-Lussenburg BM, Damsten MC, Maasdijk DM, Vermeulen NP, Commandeur JN. Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. Biochem Bioph Res Co, 2006, 346(3): 810-818.

[90] Venkataraman H, de Beer SB, van Bergen LA, van Essen N, Geerke DP, Vermeulen NP, Commandeur JN. A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3. ChemBioChem, 2012, 13(4): 520-523.

[91] Virus C, Lisurek M, Simgen B, Hannemann F, Bernhardt R. Function and engineering of the 15beta-hydroxylase CYP106A2. Biochem Soc Trans, 2006, 34: 1215-1218.

[92] Vottero E, Rea V, Lastdrager J, Honing M, Vermeulen NP, Commandeor JN. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11. J Biol Inorg Chem, 2011, 16(6): 899-912.

[93] Wang ZJ, Peck NE, Renata H, Arnold FH. Cytochrome P450-catalyzed insertion of carbenoids into N–H bonds. Chem Sci, 2014, 5: 598-601.

[94] Whitehouse CJ, Bell SG, Tufton HG, Kenny RJ, Ogilvie LC, Wong LL. Evolved CYP102A1 (P450 BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Chem Commun, 2008, 8: 966-968.

[95] Whitehouse CJ, Bell SG, Yang W, Yorke JA, Blanford CF, Strong AJ, Wong LL. A highly active single-mutation variant of P450BM3 (CYP102A1). ChemBioChem, 2009, 10(10): 1654-1656.

[96] Zhang RK, Huang X, Arnold FH. Selective CH bond functionalization with engineered heme proteins: new tools to generate complexity. Curr Opin Chem Biol, 2019, 49: 67-75.

[97] Zhou H, Wang B, Wang F, Yu X, Ma L, Li A, Reetz MT. Chemo-and regioselective dihydroxylation of benzene to hydroquinone enabled by engineered cytochrome P450 monooxygenase. Angew Chem Int Ed, 2019, 131(3): 774-778.

Funding

National Natural Science Foundation of China(21977026)